http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4076726-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f2ed19fccd5a1a9ea5e6d7846459e43 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C281-18 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C281-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C313-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-44 |
filingDate | 1975-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1978-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37198f0563fdd57ae9e5425873425b47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa4b2bb561a73c6fd4811648a699a974 |
publicationDate | 1978-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-4076726-A |
titleOfInvention | Amidino-hydrazone derivatives |
abstract | The invention relates to novel amidino-hydrazone derivatives of the general formula: ##STR1## in which the dotted lines mean one extra bond starting from the (guanidine-) carbon atom to one of the adjacent nitrogen atoms, and n A stands for methylene, ethylene, propylene or butylene, which groups may optionally be substituted with alkyl (1-4 C), n R stands for hydroxy, alkyl (1-4 C), alkylthio or alkoxy (1-4 C), halogen, trifluoromethyl, nitro, amino, hydroxymethyl, acyloxy or an alkylenedioxy group, n N is the number 0, 1, 2, 3 or 4, n R 1 , r 4 and R 5 represent hydrogen or alkyl (1-4 C), with the proviso that one of them is absent in view of the presence of the double bond, n R 2 and R 3 stand for hydrogen, alkyl (1-4 C), aralkyl, aryl, hydroxy or amino, with the proviso that n R 2 + r 3 together may also represent a saturated or unsaturated alkylene group with 2 or 3 carbon atoms, or n R 3 + r 4 together with the nitrogen atom may also stand for a heterocyclic five- or six-membered ring, n As well as the pharmaceutically acceptable acid addition salts thereof, having valuable, antihypertensive and antithrombosis activities. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5238941-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5395855-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5376685-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5639911-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0199393-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0456133-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0163888-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5461076-A |
priorityDate | 1974-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 336.